Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 10, 2004, Pages

  Mcguire, William ^a   Fowlie, Peter W ^b   Evans, David J ^c  

^a The Australian National University   (Australia)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE; NARCOTIC ANTAGONIST;

APGAR SCORE; DISEASE SEVERITY; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INFANTILE SPASM; INFORMED CONSENT; NEWBORN MORBIDITY; NEWBORN MORTALITY; PERINATAL ASPHYXIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MORTALITY; NEWBORN; NEWBORN HYPOXIA; RANDOMIZED CONTROLLED TRIAL;

ASPHYXIA NEONATORUM; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; NALOXONE; NARCOTIC ANTAGONISTS; RANDOMIZED CONTROLLED TRIALS;

EID: 2942752058     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003955.pub2     Document Type: Review

References (26)

1. Chernick V, Manfreda J, De Booy V, Davi M, Rigatto H, Seshia M. Clinical trial of naloxone in birth asphyxia. Journal of Pediatrics 1988;113:519-25.
2. Zhang SD, Qian PD, Zhang SQ, Jin LJ, Liang QJ. Effect of naloxone in treatment of neonatal hypoxic-ischemic encephalopathy. Chinese Medical Journal 1996;11:207-9.
3. American Academy of Pediatrics Committee on Drugs. Naloxone use in newborns. Pediatrics 1980;65:667-9.
4. American Academy of Pediatrics Committee on Drugs. Naloxone dosage and route of administration for infants and children: addendum to emergency drug doses for infants and children. Pediatrics 1990;86:484-5.
5. Airede AI. Birth asphyxia and hypoxic-ischaemic encephalopathy: incidence and severity. Annals of Tropical Paediatrics 1991;11:331-5.
6. Catlin EA, Carpenter MW, Brann BS 4th, Mayfield SR, Shaul PW, Goldstein M, Oh W. The Apgar score revisited: influence of gestational age. Journal of Pediatrics 1986;109:865-8.
7. Chernick V, Madansky DL, Lawson EE. Naloxone decreases the duration of primary apnea with neonatal asphyxia. Pediatric Research 1980;14:357-9.
8. Chernick V, Craig RJ. Naloxone reverses neonatal depression caused by fetal asphyxia. Science 1982;216:1252-3.
9. Evans DJ, Levene MI. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD001240.pub2]
10. Herschel M, Khoshnood B, Lass NA. Role of naloxone in newborn resuscitation. Pediatrics 2000;106:831-4.
11. Hunt R, Osborn D. Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD003484]
12. Jacobs S, Hunt R, Tarnow-Mordi W, Inder T, Davis P. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003311.pub2]
13. Kecskes Z, Healy G, Jensen A. Fluid restriction for term infants with hypoxic-ischaemic encephalopathy following perinatal asphyxia. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD004337.pub2]
14. Levene MI, Kornberg J, Williams TH. The incidence and severity of post-asphyxial encephalopathy in full-term infants. Early Human Development 1985;11:21-6.
15. Lou HC, Tweed WA, Davis JM. Endogenous opioids may protect the perinatal brain in hypoxia. Developments in Pharmacological Therapies 1989;13:129-33.
16. MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999;319:1054-9.
17. McGuire W, Fowlie P. Naloxone for narcotic exposed newborn infants. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD003483]
18. Neonatal Resuscitation Program. Textbook of Neonatal Resuscitation. 4th Edition. American Academy of Pediatrics, American Heart Association, Heart and Stroke Foundation of Canada, 2000.
19. Oswyn G, Vince JD, Friesen H. Perinatal asphyxia at Port Moresby General Hospital: a study of incidence, risk factors and outcome. Papua and New Guinea Medical Journal 2000;43:110-20.
20. Padbury JF, Agata Y, Polk DH, Wang DL, Callegari CC. Neonatal adaptation: naloxone increases the catecholamine surge at birth. Pediatric Research 1987;21:590-3.
21. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Archives of Neurology 1976;33:696-705.
22. Singh M, Deorari AK, Khajuria RC, Paul VK. A four year study on neonatal morbidity in a New Delhi hospital. Indian Journal of Medical Research 1991;94:186-92.
23. Thornberg E, Thiringer K, Odeback A, Milsom I. Birth asphyxia: incidence, clinical course and outcome in a Swedish population. Acta Paediatrica 1995;84:927-32.
24. Ting P, Pan Y. The effects of naloxone on the post-asphyxic cerebral pathophysiology of newborn lambs. Neurological Research 1994;16:359-64.
25. Young RS, Hessert TR, Pritchard GA, Yagel SK. Naloxone exacerbates hypoxic-ischemic brain injury in the neonatal rat. American Journal of Obstetetrics and Gynecology 1984;150:52-6.
26. McGuire W, Fowlie PW, Evans DJ. Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD003955.pub2]